FDA Inspection 1112681 — Biohaven Pharmaceuticals, Inc
The FDA completed an inspection of Biohaven Pharmaceuticals, Inc on Nov 7, 2019 in New Haven, CT. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 7, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- New Haven, CT (United States)
Additional details
Sponsor, Contract Research Organization